Illumina expands collaboration with Janssen to advance molecular residual disease cancer test ...Middle East

SAN DIEGO, Jan. 5, 2024 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has signed an agreement with Janssen Research & Development, LLC (Janssen). This collaboration will be the first relating to the...

Hence then, the article about illumina expands collaboration with janssen to advance molecular residual disease cancer test was published today ( Friday 05/01/2024 - 05:21 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Illumina expands collaboration with Janssen to advance molecular residual disease cancer test )

Also on site :

• EU must stop funding Kiev after Zelensky’s ‘insults’ – Italian MP
• The One Florida Hotel Family Travel Advisors Book on Repeat—and It’s Not Disney
• Why Is This Beloved 'Scrubs' Character Missing From the Reboot? Zach Braff Explains